Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Countries and organisations

Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.

Free access · No subscription for research tools or data exports

Explore registry geography and organisations

Reset

41 trials match this view; 188 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 2,726 across 41 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

201911
202122
202222
202366
202477
20251010
20261313

Current indexed registry status

Recruiting1515
Active, not recruiting88
Completed77
Not yet recruiting55
Unknown status33
Enrolling by invitation11
Suspended11
Withdrawn11

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Matching trial records

41 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial

NCT06386003

Post Traumatic Stress Disorder · PTSD · Chronic PTSD
Unity Health Toronto

PHASE2

Active, not recruiting

Registry updated 2026-10-06

15

ESTIMATED

2026-06-01
2028-01
2028-06
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

NCT07570654

PTSD - Post Traumatic Stress Disorder · PTSD · PTSD Symptoms · PTSD, Post Traumatic Stress Disorder
COMPASS Pathways

PHASE2, PHASE3

Recruiting

Registry updated 2026-10-06

300

ESTIMATED

2026-09
2028-11
2029-09
Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment

NCT06041152

Amnestic Mild Cognitive Impairment
Centre for Addiction and Mental Health

PHASE2

Completed

Registry updated 2026-10-05

10

ACTUAL

2023-11-27
2026-02-19
2026-02-19
Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial

NCT06299319

Obsessive-Compulsive Disorder
Centre for Addiction and Mental Health

PHASE1

Completed

Registry updated 2026-09-24

10

ACTUAL

2024-09-01
2026-09-04
2026-09-04
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

NCT07820033

Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer
University Health Network, Toronto

PHASE2

Not yet recruiting

Registry updated 2026-09-15

46

ESTIMATED

2026-09-14
2028-12-30
2029-07-30
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial

NCT06943573

Bipolar II Depression
Lakshmi N Yatham

PHASE2

Recruiting

Registry updated 2026-09-15

90

ESTIMATED

2026-06-15
2028-12
2028-12
A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial

NCT06615908

Persisting Symptoms After Concussion
University of Calgary

PHASE1

Recruiting

Registry updated 2026-09-09

40

ESTIMATED

2025-05-27
2027-06-30
2027-12-30
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence

NCT06885996

Post Traumatic Stress Disorder PTSD · Intimate Partner Violence (IPV)
University of Calgary

PHASE2

Not yet recruiting

Registry updated 2026-09-08

76

ESTIMATED

2026-10-01
2028-08-01
2029-08-01
High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite Trial

NCT07791901

Advanced Cancer · Demoralization · Existential Distress · Psychological Distress
University of Calgary

PHASE2

Not yet recruiting

Registry updated 2026-09-02

60

ESTIMATED

2026-10-30
2027-12-20
2027-12-31
The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults

NCT06768944

Investigating the Importance of the Subjective Psychedelic Experience
University of Calgary

PHASE2

Recruiting

Registry updated 2026-09-02

128

ESTIMATED

2026-05-15
2027-12
2028-01
An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study

NCT06225232

Cannabis Use Disorder, Moderate · Cannabis Use Disorder, Severe
McMaster University

PHASE2

Active, not recruiting

Registry updated 2026-08-31

16

ESTIMATED

2025-03-21
2026-12
2026-12
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial

NCT07211438

Treatment-Resistant Depression
Centre for Addiction and Mental Health

PHASE2

Recruiting

Registry updated 2026-08-21

40

ESTIMATED

2026-07-03
2028-07
2029-01
A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

NCT06969170

Generalized Anxiety Disorder (GAD)
Claudio N Soares

PHASE2

Recruiting

Registry updated 2026-08-12

50

ESTIMATED

2025-05-16
2027-12-31
2028-12-30
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression

NCT05711940

Treatment Resistant Depression
COMPASS Pathways

PHASE3

Active, not recruiting

Registry updated 2026-08-10

572

ACTUAL

2023-02-14
2025-11-13
2026-12
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study

NCT06506019

Bipolar Depression
University Health Network, Toronto

PHASE1

Active, not recruiting

Registry updated 2026-08-10

30

ESTIMATED

2024-10-09
2026-09-01
2027-01-01
Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism

NCT06731621

Treatment Resistant Depression · Autism Spectrum Disorder
Centre for Addiction and Mental Health

PHASE1

Active, not recruiting

Registry updated 2026-08-06

20

ESTIMATED

2024-11-01
2026-12
2026-12
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression

NCT07737990

Treatment-resistant Depression (TRD)
Joshua Rosenblat

NA

Enrolling by invitation

Registry updated 2026-07-30

65

ESTIMATED

2026-07-01
2029-12-31
2030-06-30
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

NCT06512220

Treatment Resistant Depression
Centre for Addiction and Mental Health

PHASE2

Recruiting

Registry updated 2026-07-30

12

ESTIMATED

2025-04-21
2027-04
2027-09
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial

NCT06518720

Treatment Resistant Depression · Chronic Pain
Centre for Addiction and Mental Health

PHASE2

Recruiting

Registry updated 2026-07-30

16

ESTIMATED

2025-04-01
2027-03
2027-12
A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin

NCT07710027

Healthy Controls
Diamond Therapeutics Inc.

PHASE1

Completed

Registry updated 2026-07-17

56

ACTUAL

2021-10-19
2022-03-12
2023-03-12
PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial

NCT07063862

Psychological Distress
Bruyère Health Research Institute.

PHASE3

Recruiting

Registry updated 2026-07-10

120

ESTIMATED

2026-01-28
2027-08
2027-09
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial

NCT04754061

Depression, Anxiety · Distress, Emotional
Ottawa Hospital Research Institute

PHASE1, PHASE2

Active, not recruiting

Registry updated 2026-07-10

20

ESTIMATED

2024-01-08
2026-10-01
2027-01-01
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)

NCT06341426

Major Depressive Disorder · Depression · Treatment-Resistant Depression · Mood Disorders
University Health Network, Toronto

PHASE2

Active, not recruiting

Registry updated 2026-07-09

92

ESTIMATED

2024-02-05
2026-07-28
2026-12-28
Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial

NCT07048743

Caregiver Distress
University Health Network, Toronto

PHASE2

Recruiting

Registry updated 2026-06-23

15

ESTIMATED

2025-07-16
2027-12-02
2027-12-02
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial

NCT06416085

Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer
University Health Network, Toronto

PHASE2

Active, not recruiting

Registry updated 2026-06-22

15

ESTIMATED

2024-06-06
2026-12-15
2026-12-15
Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial

NCT05710237

Treatment-resistant Depression
Centre for Addiction and Mental Health

PHASE2

Completed

Registry updated 2026-05-07

41

ACTUAL

2023-07-01
2026-04-14
2026-04-14
Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy

NCT07373535

Treatment-Resistant Major Depressive Disorder
Kyle Greenway

PHASE2

Not yet recruiting

Registry updated 2026-04-22

16

ESTIMATED

2026-05
2028-07
2028-12
Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression

NCT06072898

Depressive Disorder · Major Depressive Disorder
Sunnybrook Health Sciences Centre

PHASE2

Recruiting

Registry updated 2026-03-30

50

ESTIMATED

2025-05-28
2028-05
2029-05
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study

NCT06818994

Demoralization · Safety
Gustavo Vazquez

PHASE1

Recruiting

Registry updated 2026-03-18

15

ESTIMATED

2026-04-01
2027-06-01
2027-06-01
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial

NCT07405606

Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD)
Centre for Addiction and Mental Health

PHASE2

Not yet recruiting

Registry updated 2026-02-12

30

ESTIMATED

2026-03
2028-03
2028-06
Microdosing Psychedelics to Improve Mood

NCT05259943

Major Depressive Disorder
Rotem Petranker

PHASE2

Completed

Registry updated 2025-12-30

39

ACTUAL

2023-07-15
2024-12-21
2025-02-01
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study

NCT05585229

Opioid Dependence · Chronic Pain
University of British Columbia

PHASE2

Recruiting

Registry updated 2025-12-04

10

ESTIMATED

2025-10-27
2026-08-31
2026-08-31
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

NCT06731335

Chronic Neuropathic Pain · Pain Management
Unity Health Toronto

PHASE2

Recruiting

Registry updated 2025-03-30

30

ESTIMATED

2025-03-05
2026-08
2026-12
A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

NCT05646303

Alcohol Use Disorder
Clairvoyant Therapeutics

PHASE2

Unknown status

Registry updated 2024-08-15

128

ESTIMATED

2022-05-02
2024-08-31
2024-12-31
Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders

NCT06471959

Psilocybin · Psychotherapy, Group
Empower Research Inc

PHASE1, PHASE2

Unknown status

Registry updated 2024-06-24

32

ESTIMATED

2025-01-01
2025-07-01
2025-09-01
An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients

NCT05832255

Fragile X Syndrome · Behavior · Cognitive Dysfunction
Nova Mentis Life Science Corp

PHASE2

Suspended

Registry updated 2024-05-08

10

ESTIMATED

2023-03-28
2024-05
2024-05
Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial

NCT05995769

Alcohol Use Disorder · Alcoholism
University of Calgary

PHASE2

Recruiting

Registry updated 2024-05-07

128

ESTIMATED

2024-03-20
2027-10-01
2027-10-01
The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study

NCT05029466

Treatment Resistant Depression
Brain and Cognition Discovery Foundation

PHASE2

Completed

Registry updated 2023-07-27

30

ACTUAL

2021-11-19
2023-07-22
2023-07-22
Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)

NCT05594667

Depression · Major Depressive Disorder · Mild Depression · Moderate Depression · Depressive Disorder
Cybin Therapeutics Inc.

PHASE2

Withdrawn

Registry updated 2023-07-06

0

ACTUAL

2023-01-01
2023-03-14
2023-03-14
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

NCT05243329

Treatment Resistant Disorders · Post Traumatic Stress Disorder
Halucenex Life Sciences Inc.

PHASE2

Unknown status

Registry updated 2023-06-29

20

ESTIMATED

2022-10-03
2023-10-30
2023-12-30
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

NCT03775200

Treatment Resistant Depression
COMPASS Pathways

PHASE2

Completed

Registry updated 2023-04-24

233

ACTUAL

2019-03-01
2021-07-30
2021-09-27

Reported research facilities

St. Michael's Hospital, Unity Health TorontoToronto, Ontario, Canada
FLMiami, Florida, United States
FLOrlando, Florida, United States
ILChicago, Illinois, United States
MNEden Prairie, Minnesota, United States
NELincoln, Nebraska, United States
NVLas Vegas, Nevada, United States
NYNew York, New York, United States
BCNorth Vancouver, British Columbia, Canada
Centre for Addiction and Mental HealthToronto, Ontario, Canada
University Health NetworkToronto, Ontario, Canada
Djavad Mowafaghian Centre for Brain HealthVancouver, British Columbia, Canada
Department of Psychiatry, University of Ottawa, The Ottawa HospitalOttawa, Ontario, Canada
Department of Psychiatry, University of Toronto, University Health Network,Toronto, Ontario, Canada
University of CalgaryCalgary, Alberta, Canada
The University of British Columbia - Okanagan CampusKelowna, British Columbia, Canada
Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada
Providence Care HospitalKingston, Ontario, Canada
MacAnxiety Research CentreHamilton, Ontario, Canada
Toronto Western Hospital (University Health Network)Toronto, Ontario, Canada
Kingston General Health Research InstituteKingston, Ontario, Canada
Lighthouse Psychiatry ScottsdaleGilbert, Arizona, United States
Clinical Innovations, Inc.Bellflower, California, United States
M3 Wake ResearchEncino, California, United States
The Regents of the University of California - San DiegoLa Jolla, California, United States
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
CalNeuro Research Group, IncLos Angeles, California, United States
Catalina Research Institute, LLCMontclair, California, United States
Piedmont Hospital Neuroscience CentreOakland, California, United States
ATP Clinical Research, Inc.Orange, California, United States
CITrialsRiverside, California, United States
Lumos Clinical Research CenterSan Jose, California, United States
Syrentis Clinical ResearchSanta Ana, California, United States
Stanford UniversityStanford, California, United States
ASCLEPES Research CentersThousand Oaks, California, United States
Pacific Clinical Research Management Group, LLCUpland, California, United States
Innovative Clinical Research, Inc.Lauderhill, Florida, United States
Central Miami Medical Institute, LLCMiami, Florida, United States
Behavioral Clinical Research, Inc.Miami Lakes, Florida, United States
Health Synergy Clinical ResearchOkeechobee, Florida, United States
Clinical Neurosciecne Solutions, Inc. dba CNS HealthcareOrlando, Florida, United States
APG Research, LLC- Advanced Psychiatric GroupOrlando, Florida, United States
University South FloridaTampa, Florida, United States
Stedman Clinical TrialsTampa, Florida, United States
Health Synergy Clinical Research, LLCWest Palm Beach, Florida, United States
Atlanta Center for Medical ResearchAtlanta, Georgia, United States
iResearch AtlantaDecatur, Georgia, United States
Rush University Medical CenterChicago, Illinois, United States
Uptown Research Institute, LLCChicago, Illinois, United States
Psychiatric Medicine AssociatesSkokie, Illinois, United States
Harvard Medical School - McLean HospitalBelmont, Massachusetts, United States
Adams Clinical - Boston (Copley Clinical)Boston, Massachusetts, United States
University of Massachusetts Medical SchoolNorth Worcester, Massachusetts, United States
Adams Clinical - BostonWatertown, Massachusetts, United States
Michigan Clinical Research Institute PCAnn Arbor, Michigan, United States
University Of Michigan Comprehensive Depression CenterAnn Arbor, Michigan, United States
Institute for Integrative TherapiesEden Prairie, Minnesota, United States
St. Charles Psychiatric Associates - Midwest Research GroupSaint Charles, Missouri, United States
Alivation Research, LLC.Lincoln, Nebraska, United States
Hassman Research InstituteBerlin, New Jersey, United States
Princeton Medical InstitutePrinceton, New Jersey, United States
Bio Behavioral HealthToms River, New Jersey, United States
Dent Neurosciences Research Center, Inc.Amherst, New York, United States
Fieve Clinical Research, IncNew York, New York, United States
Spectrum Neuroscience and Treatment InstituteNew York, New York, United States
Adams Clinical - New YorkNew York, New York, United States
New York State Psychiatric InstituteNew York, New York, United States
Richmond Behavioral AssociatesStaten Island, New York, United States
Adams Clinical - New YorkThe Bronx, New York, United States
University of Cincinnati, Department of Psychiatry & Behavirol NeuroscienceCincinnati, Ohio, United States
Cleveland Clinic - Lutheran HospitalCleveland, Ohio, United States
The Ohio State UniversityColumbus, Ohio, United States
Suburban Research AssociatesMedia, Pennsylvania, United States
The University of Texas at Austin - Dell Medical SchoolAustin, Texas, United States
Houston Clinical Trials, LLCBellaire, Texas, United States
Relaro Medical TrialsDallas, Texas, United States
Center for Depression Research and Clinical CareDallas, Texas, United States
North Texas Clinical TrialsFort Worth, Texas, United States
Brain Health Consultants and TMS CenterHouston, Texas, United States
HCA Healthcare Research Institute - Medical City Green Oaks HospitalPlano, Texas, United States
Cedar Clinical ResearchDraper, Utah, United States
The University of Utah - Huntsman Mental Health InstituteSalt Lake City, Utah, United States
Seattle Neuropsychiatric Treatment CenterSeattle, Washington, United States
Diex Recherche Sherbrooke Inc.Québec, B.C., Canada
Medical Arts Health Research Centre, KamloopsKamloops, British Columbia, Canada
Okanagan Clinical TrialsKelowna, British Columbia, Canada
Medical Arts Research Group - PentictonPenticton, British Columbia, Canada
Chatham-Kent Clnical Trials CentreChatham, Ontario, Canada
St. Michael's HospitalToronto, Ontario, Canada
Centre for Addiction and Mental Health (CAMH)Toronto, Ontario, Canada
Centre for Neurology StudiesVancouver, Canada
Medical Arts Research GroupVancouver, Canada
National Institute of Mental HealthKlecany, Czechia
Neuroterapie KH SroKutná Hora, Czechia
Psychiatric AmbulanceOstrava, Czechia
A-Shine s.r.o.Pilsen, Czechia
Psychedelicka klinika, s.r.o.Prague, Czechia
Institut Neuropsychiatricke PecePrague, Czechia
Aalborg Universitetshospital-Psykiatrien Region NordjyllandAalborg, Denmark
Ghu-Centre Hospitalier Sainte Anne, Centre de Recherche CliniqueParis, Paris, France
Centre Hospitalier Universitaire de Nimes (CHU) - Hopital Universitaire CaremeauNîmes, France
Universite Paris VI Pierre et Marie Curie - Hopital de La Salpetriere - Centre Emotion - USR 3246 (CNRS UMR 7593)Paris, France
Centre Hospitalier Sainte Anne - Clinique des Maladies Mentales et de l'Encephale (CMME)Paris, France
Charite-Universitaetsmedizin BerlinBerlin, Germany
Johann Wolfgang Goethe-Universitaet Frankfurt am Main - Klinik fuer Psychiatrie, Psychosomatik und PsychotherapieFrankfurt, Germany
ZiP Campus LuebeckLübeck, Germany
Tallaght University HospitalDublin, Ireland
La Nua Day Hospital Mental Health CentreGalway, Ireland
University Medical Center GroningenGroningen, Netherlands
Leids Universitair Medisch Centrum (LUMC) (Leiden University Medical Center) - Leiden Institute for Brain and Cognition (LIBC)Leiden, Netherlands
Universitair Medisch Centrum Utrecht (UMC Utrecht)Utrecht, Netherlands
Promente - Ośrodek Badań KlinicznychBydgoszcz, Poland
Uniwersyteckle Centrum Kliniczne, Klinika Psychiatrii DoroslychGdansk, Poland
Centrum Badan Klinicznych PI-House Sp. z o.o.Gdansk, Poland
Hospital Clinic de BarcelonaBarcelona, Spain
Parc Sanitari Sant Joan de Deu (Sant Joan de Deu Serveis de Salut Mental)Barcelona, Spain
Hospital Universitario Fundacion Jimenez DiazMadrid, Spain
FIDMAG Hermanas HospitalariasSant Boi de Llobregat, Spain
Hospital Universitario Río Hortega de ValladolidValladolid, Spain
Hospital Provincial de Zamora - Servicio de PsiquiatriaZamora, Spain
VuxenpsykiatrimottagningenLandskrona, Sweden
Lunds Universitet - Medicinska Fakulteten (Lund University Faculty of Medicine)Lund, Sweden
ClinSmart Sweden ABSolna, Sweden
HälsoklustretStockholm, Sweden
Cornwall Partnership NHS Foundation TrustBodmin, Cornwall, United Kingdom
Abraham Cowley Unit - Surrey and Borders Partnership NHS Foundation TrustChertsey, United Kingdom
St. Pancras Clinical ResearchChester, United Kingdom
Grounded Research Hub - Rotherham Doncaster & South Humber NHS Foundation TrustDoncaster, United Kingdom
Clinical Research Facility, Royal Devon and Exeter HospitalExeter, United Kingdom
Fulbourn Hospital - Cambridgeshire And Peterborough NHS Foundation TrustFulbourn, United Kingdom
St. Pancras Clinical ResearchLondon, United Kingdom
King's College London - Institute of Psychiatry, PsychologyLondon, United Kingdom
Clerkenwell HealthLondon, United Kingdom
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust - Wolfson Research CentreNewcastle, United Kingdom
University Of Nottingham/Nottinghamshire Healthcare Trust, Institute Of Mental HealthNottingham, United Kingdom
The Warneford Hospital- NIHR Clinical Research FacilityOxford, United Kingdom
Sheffield Health and Social Care NHS Foundation TrustSheffield, United Kingdom
Toronto Western Hospital - University Health NetworkToronto, Ontario, Canada
Toronto Western HospitalToronto, Ontario, Canada
BioPharma Services Inc.Toronto, Ontario, Canada
William Osler Health SystemBrampton, Ontario, Canada
St. Joseph's HealthcareLondon, Ontario, Canada
South Lake Regional Health CentreNewmarket, Ontario, Canada
Bruyere HealthOttawa, Ontario, Canada
The Ottawa HospitalOttawa, Ontario, Canada
McGill University Health CentreMontreal, Quebec, Canada
Bruyere Continuing CareOttawa, Ontario, Canada
Toronto General HospitalToronto, Ontario, Canada
Princess Margaret Cancer CentreToronto, Ontario, Canada
Jewish General HospitalMontreal, Quebec, Canada
Sunnybrook Health Sciences CentreToronto, Ontario, Canada
Queen's UniversityKingston, Ontario, Canada
Psych ResearchToronto, Ontario, Canada
University of British Columbia - Okanagan CampusKelowna, British Columbia, Canada
St. Michael's Hospital. Unity Health TorontoToronto, Ontario, Canada
Sabi MindCalgary, Alberta, Canada
Centre for Neurology StudiesSurrey, British Columbia, Canada
University of British Columbia, Department of Psychiatry, BRAIN LabVancouver, British Columbia, Canada
Centricity ResearchHalifax, Nova Scotia, Canada
Department of Psychiatry, Queen's UniversityKingston, Ontario, Canada
Research Center Oxidi Oy / Addiktum OyHelsinki, Finland
A-KlinikkaKouvola, Finland
Mentacare OyOulu, Finland
Addiktum OyTurku, Finland
KGK Science Inc.London, Ontario, Canada
Canadian Rapid Treatment Centre of Excellence (CRTCE)Mississauga, Ontario, Canada
Centre for Neurology Studies x UpstreamAbbotsford British Columbia, British Columbia, Canada
Halucenex Life Sciences Inc.Windsor, Nova Scotia, Canada
Altman Clinical and Translational Research Institute, University of CaliforniaSan Diego, California, United States
Stanford Department of PsychiatryStanford, California, United States
Mood and Anxiety Disorders Program Emory University School of MedicineAtlanta, Georgia, United States
Ray Worthy Psychiatry LLCNew Orleans, Louisiana, United States
Sheppard Pratt Health SystemBaltimore, Maryland, United States
UT Center of Excellence on Mood Disorders, University of Texas Health Science CenterHouston, Texas, United States
Canadian Rapid Treatment Centre of ExcellenceMississauga, Ontario, Canada
National Institute of Mental Health Czech RepublicKlecany, Czechia
Enhed for Psykiatrisk Forskning, Psykiatrien i AalborgAalborg, Denmark
Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin FranklinBerlin, Germany
Groningen University Medical CentreGroningen, Netherlands
Leiden University Medical CentreLeiden, Netherlands
Utrecht University Medical CentreUtrecht, Netherlands
Unidade de Neuropsiquiatria, Centro Clinico ChampalimaudLisbon, Portugal
Hospital de Dia NumanciaBarcelona, Spain
Institute Hospital del Mar of Medical Research (IMIM)Barcelona, Spain
Clinical Research and Imaging CentreBristol, Avon, United Kingdom
Wolfson Research Centre, Campus for Ageing and VitalityNewcastle upon Tyne, Tyne and Wear, United Kingdom
Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom
Greater Manchester Mental Health Foundation TrustManchester, United Kingdom

This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.